Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusion

Neuroscience

Volumn 212, Issue , 2012, Pages 180-189

  Suofu, Y ^a   Clark, J F ^a   Broderick, J P ^a   Kurosawa, Y ^a   Wagner, K R ^a   Lu, A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Cerebral ischemia; Hemorrhagic transformation; Mice; MMP 2 knockout; MMP 2 9 double knockout; MMP 9 knockout

Indexed keywords

GELATINASE A; GELATINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BLOOD VOLUME; BRAIN CORTEX; BRAIN FUNCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE CLASSIFICATION; ENZYME DEFICIENCY; GELATINASE A DEFICIENCY; GELATINASE B DEFICIENCY; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; REPERFUSION INJURY;

ANIMALS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; DISEASE MODELS, ANIMAL; FEMALE; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REPERFUSION INJURY;

EID: 84861665494     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.03.036     Document Type: Article

References (38)

1. Asahi M., Asahi K., Jung J.C., del Zoppo G.J., Fini M.E., Lo E.H. Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab 2000, 20:1681-1689.
2. Asahi M., Sumii T., Fini M.E., Itohara S., Lo E.H. Matrix metalloproteinase 2 gene knockout has no effect on acute brain injury after focal ischemia. Neuroreport 2001, 12:3003-3007.
3. Asahi M., Wang X., Mori T., Sumii T., Jung J.C., Moskowitz M.A., Fini M.E., Lo E.H. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 2001, 21:7724-7732.
4. Banisadr G., Skrzydelski D., Kitabgi P., Rostene W., Parsadaniantz S.M. Highly regionalized distribution of stromal cell-derived factor-1/CXCL12 in adult rat brain: constitutive expression in cholinergic, dopaminergic and vasopressinergic neurons. Eur J Neurosci 2003, 18:1593-1606.
5. Belaaouaj A.A., Li A., Wun T.C., Welgus H.G., Shapiro S.D. Matrix metalloproteinases cleave tissue factor pathway inhibitor. Effects on coagulation. J Biol Chem 2000, 275:27123-27128.
6. Belayev L., Saul I., Curbelo K., Busto R., Belayev A., Zhang Y., Riyamongkol P., Zhao W., Ginsberg M.D. Experimental intracerebral hemorrhage in the mouse: histological, behavioral, and hemodynamic characterization of a double-injection model. Stroke 2003, 34:2221-2227.
7. Choi B.H., Suzuki M., Kim T., Wagner S.L., Cunningham D.D. Protease nexin-1. Localization in the human brain suggests a protective role against extravasated serine proteases. Am J Pathol 1990, 137:741-747.
8. del Zoppo G.J. The neurovascular unit, matrix proteases, and innate inflammation. Ann NY Acad Sci 2010, 1207:46-49.
9. Engel O., Kolodziej S., Dirnagl U., Prinz V. Modeling stroke in mice - middle cerebral artery occlusion with the filament model. J Vis Exp 2011, 2423.
10. Fujimura M., Gasche Y., Morita-Fujimura Y., Massengale J., Kawase M., Chan P.H. Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res 1999, 842:92-100.
11. Gasche Y., Fujimura M., Morita-Fujimura Y., Copin J.C., Kawase M., Massengale J., Chan P.H. Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction. J Cereb Blood Flow Metab 1999, 19:1020-1028.
12. Gu Z., Cui J., Brown S., Fridman R., Mobashery S., Strongin A.Y., Lipton S.A. A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J Neurosci 2005, 25:6401-6408.
13. Heo J.H., Lucero J., Abumiya T., Koziol J.A., Copeland B.R., del Zoppo G.J. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J Cereb Blood Flow Metab 1999, 19:624-633.
14. Hiraoka N., Allen E., Apel I.J., Gyetko M.R., Weiss S.J. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 1998, 95:365-377.
15. Itoh T., Ikeda T., Gomi H., Nakao S., Suzuki T., Itohara S. Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J Biol Chem 1997, 272:22389-22392.
16. Lapchak P.A., Chapman D.F., Zivin J.A. Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke. Stroke 2000, 31:3034-3040.
17. Levi E., Fridman R., Miao H.Q., Ma Y.S., Yayon A., Vlodavsky I. Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. Proc Natl Acad Sci USA 1996, 93:7069-7074.
18. Liu F., Schafer D.P., McCullough L.D. TTC, fluoro-Jade B and NeuN staining confirm evolving phases of infarction induced by middle cerebral artery occlusion. J Neurosci Methods 2009, 179:1-8.
19. Lu A., Clark JF., Broderick JP., Pyne-Geithman GJ., Wagner KR., Khatri P., Tomsick T., Sharp FR. Mechanical reperfusion is associated with post-ischemic hemorrhage in rat brain. Exp Neurol 2009, 216:407-412. [Epub 2009 January 2007].
20. Lu A., Clark J.F., Broderick J.P., Pyne-Geithman G.J., Wagner K.R., Ran R., Khatri P., Tomsick T., Sharp F.R. Reperfusion activates metalloproteinases that contribute to neurovascular injury. Exp Neurol 2008, 210:549-559.
21. Maeda K., Hata R., Hossmann K.A. Differences in the cerebrovascular anatomy of C57black/6 and SV129 mice. Neuroreport 1998, 9:1317-1319.
22. Monaco S., Gioia M., Rodriguez J., Fasciglione G.F., Di Pierro D., Lupidi G., Krippahl L., Marini S., Coletta M. Modulation of the proteolytic activity of matrix metalloproteinase-2 (gelatinase A) on fibrinogen. Biochem J 2007, 402:503-513.
23. Morishige K., Shimokawa H., Matsumoto Y., Eto Y., Uwatoku T., Abe K., Sueishi K., Takeshita A. Overexpression of matrix metalloproteinase-9 promotes intravascular thrombus formation in porcine coronary arteries in vivo. Cardiovasc Res 2003, 57:572-585.
24. Planas A.M., Sole S., Justicia C. Expression and activation of matrix metalloproteinase-2 and -9 in rat brain after transient focal cerebral ischemia. Neurobiol Dis 2001, 8:834-846.
25. Ramos-Fernandez M., Bellolio M.F., Stead L.G. Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review. J Stroke Cerebrovasc Dis 2011, 20:47-54.
26. Rodriguez D., Morrison C.J., Overall C.M. Matrix metalloproteinases: what do they not do? New substrates and biological roles identified by murine models and proteomics. Biochim Biophys Acta 2010, 1803:39-54.
27. Rosenberg G.A., Cunningham L.A., Wallace J., Alexander S., Estrada E.Y., Grossetete M., Razhagi A., Miller K., Gearing A. Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res 2001, 893:104-112.
28. Rosenberg G.A., Estrada E.Y., Dencoff J.E. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 1998, 29:2189-2195.
29. Smith W.S. Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. AJNR Am J Neuroradiol 2006, 27:1177-1182.
30. Stemer A., Lyden P. Evolution of the thrombolytic treatment window for acute ischemic stroke. Curr Neurol Neurosci Rep 2010, 10:29-33.
31. Sumii T., Lo E.H. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke 2002, 33:831-836.
32. Suofu Y., Clark J., Broderick J., Wagner K.R., Tomsick T., Sa Y., Lu A. Peroxynitrite decomposition catalyst prevents matrix metalloproteinase activation and neurovascular injury after prolonged cerebral ischemia in rats. J Neurochem 2010, 115:1266-1276.
33. Suzuki Y., Nagai N., Umemura K., Collen D., Lijnen H.R. Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in mice. J Thromb Haemost 2007, 5:1732-1739.
34. Tang J., Liu J., Zhou C., Alexander J.S., Nanda A., Granger D.N., Zhang J.H. Mmp-9 deficiency enhances collagenase-induced intracerebral hemorrhage and brain injury in mutant mice. J Cereb Blood Flow Metab 2004, 24:1133-1145.
35. Wagner S.L., Geddes J.W., Cotman C.W., Lau A.L., Gurwitz D., Isackson P.J., Cunningham D.D. Protease nexin-1, an antithrombin with neurite outgrowth activity, is reduced in Alzheimer disease. Proc Natl Acad Sci USA 1989, 86:8284-8288.
36. Xu D., McKee C.M., Cao Y., Ding Y., Kessler B.M., Muschel R.J. Matrix metalloproteinase-9 regulates tumor cell invasion through cleavage of protease nexin-1. Cancer Res 2010, 70:6988-6998.
37. Yang Y., Estrada E.Y., Thompson J.F., Liu W., Rosenberg G.A. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab 2007, 27:697-709.
38. Zhang K., McQuibban G.A., Silva C., Butler G.S., Johnston J.B., Holden J., Clark-Lewis I., Overall C.M., Power C. HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Nat Neurosci 2003, 6:1064-1071.